Table 2.
Comparative analysis of the discrimination of each systemic inflammation‐related biomarkers for all‐cause mortality in non‐small cell lung cancer
| Discrimination ability | C‐statistic | ||
|---|---|---|---|
| Difference | Difference | P value | |
| IBI | 0.640(0.617,0.663) | Ref | |
| NLR | 0.633(0.610,0.656) | −0.007(−0.025, 0.013) | 0.470 |
| CALLY | 0.631(0.608,0.655) | −0.008(−0.015, −0.001) | 0.018 |
| LCR | 0.629(0.606,0.653) | −0.011(−0.018, −0.004) | 0.003 |
| NC | 0.629(0.606,0.652) | −0.011(−0.017, −0.005) | <0.001 |
| CAR | 0.623(0.599,0.646) | −0.017(−0.025, −0.009) | <0.001 |
| SII | 0.614(0.591,0.638) | −0.026(−0.044, −0.007) | 0.007 |
| GPS | 0.610(0.588,0.631) | −0.030(−0.044, −0.017) | <0.001 |
| NAR | 0.614(0.590,0.638) | −0.026(−0.046, −0.005) | 0.013 |
| PC | 0.611(0.588,0.635) | −0.029(−0.038, −0.019) | <0.001 |
| mGPS | 0.605(0.584,0.626) | −0.035(−0.048, −0.022) | <0.001 |
| PLR | 0.580(0.556,0.604) | −0.060(−0.082, −0.038) | <0.001 |
| NP | 0.579(0.555,0.603) | −0.061(−0.085, −0.038) | <0.001 |
| LA | 0.581(0.557,0.604) | −0.059(−0.084, −0.035) | <0.001 |
| LCS | 0.567(0.547,0.588) | −0.072(−0.089, −0.054) | <0.001 |
| PAR | 0.550(0.526,0.574) | −0.090(−0.114, −0.065) | <0.001 |
CALLY, C‐reactive protein–albumin–lymphocyte index; CAR, C‐reactive protein‐to‐albumin ratio; GPS, Glasgow Prognostic Score; IBI, inflammatory burden index; LA, lymphocyte–albumin score; LCR, lymphocyte‐to‐C‐reactive protein ratio; LCS, lymphocyte C‐reactive protein score; mGPS, Modified Glasgow Prognostic Score; NAR, neutrophil‐to‐albumin ratio; NC, neutrophil‐C‐reactive protein score; NLR, neutrophil‐to‐lymphocyte ratio; NP, neutrophil–platelet score; PAR, platelet‐to‐albumin ratio; PC, platelet‐C‐reactive protein score; PLR, platelet‐to‐Lymphocyte ratio; SII, systemic‐immune‐inflammation index.